AbbVie (ABBV) Change in Cash (2012 - 2026)

AbbVie (ABBV) has reported Change in Cash for 15 consecutive years, with -$2.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Cash fell 318.42% year-over-year to -$2.8 billion in Q2 2026; TTM through Jun 2026 was $102.0 million, a 101.53% increase from a year earlier, with the FY2025 full-year figure at -$295.0 million, up 95.95% from the prior year.
• Change in Cash was -$2.8 billion for Q2 2026 at AbbVie, down from $4.2 billion in the prior quarter.
• Over five years, Change in Cash peaked at $5.3 billion in Q1 2024 and troughed at -$5.9 billion in Q3 2024.
• A 5-year average of -$176.5 million and a median of -$436.5 million in 2023 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash slumped 379.33% in 2022 and surged 1292.55% in 2026, its largest moves.
• Over 5 years, Change in Cash stood at -$2.6 billion in 2022, then soared by 82.02% to -$473.0 million in 2023, then tumbled by 266.38% to -$1.7 billion in 2024, then surged by 76.92% to -$400.0 million in 2025, then plunged by 605.5% to -$2.8 billion in 2026.
• The last three Change in Cash figures came in at -$2.8 billion (Q2 2026), $4.2 billion (Q1 2026), and -$400.0 million (Q4 2025), per Business Quant data.